FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2017008870> ?p ?o ?g. }

• W2017008870 endingPage "162" @default.
• W2017008870 startingPage "156" @default.
• W2017008870 abstract "<i>Purpose:</i> Detrusor overactivity and urethral sphincter pseudodyssynergia may develop during recovery from cerebrovascular accidents or intracranial lesions, resulting in difficulty in urination, a large amount of residual urine, and recurrent urinary tract infection. This study evaluated the effectiveness of urethral injection of botulinum A toxin in treating these patients. <i>Methods:</i> Twenty-one patients with chronic cerebrovascular accidents or intracranial lesions and difficult urination were enrolled. Patients participating in the study elected to receive either 100 units of botulinum A toxin (n = 11) or served as medically treated controls (n = 10). The urodynamic parameters and voiding efficiency after treatment were compared between the 2 groups. <i>Results:</i> An excellent result was obtained in 6 patients and an improved result in 4 patients, resulting in an overall success rate of 91% in the study group. Four patients with frank urinary retention before treatment resumed spontaneous voiding. The maximal effects of botulinum A toxin appeared about 2 weeks after treatment. The voiding pressure decreased (57.8 ± 35.2 vs. 33.8 ± 16.9 cm H₂O, p = 0.005) and the maximal flow rate increased (7.2 ± 5.9 vs. 10.3 ± 5.2 ml/s, p = 0.005) significantly. In the control group, 4 patients (40%) had spontaneous voiding 6 months after medical treatment, whereas 6 patients remained unchanged requiring an indwelling Foley catheter (n = 2) or clean intermittent catheterization (n = 4). The symptom score and the quality of life index showed significantly greater improvement in the study group than in the control group. <i>Conclusion:</i> This study demonstrates that urethral injection of botulinum A toxin is effective and without adverse effects in the treatment of patients with urethral sphincter pseudodyssynergia after cerebrovascular accidents or the development of intracranial lesions." @default.
• W2017008870 created "2016-06-24" @default.
• W2017008870 creator A5020166018 @default.
• W2017008870 creator A5053694613 @default.
• W2017008870 date "2004-01-01" @default.
• W2017008870 modified "2023-09-27" @default.
• W2017008870 title "Botulinum A Toxin Treatment of Urethral Sphincter Pseudodyssynergia in Patients with Cerebrovascular Accidents or Intracranial Lesions" @default.
• W2017008870 cites W1969418692 @default.
• W2017008870 cites W1977614603 @default.
• W2017008870 cites W2063440492 @default.
• W2017008870 cites W4211080745 @default.
• W2017008870 cites W4238739683 @default.
• W2017008870 cites W4242049826 @default.
• W2017008870 doi "https://doi.org/10.1159/000079697" @default.
• W2017008870 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15331901" @default.
• W2017008870 hasPublicationYear "2004" @default.
• W2017008870 type Work @default.
• W2017008870 sameAs 2017008870 @default.
• W2017008870 citedByCount "25" @default.
• W2017008870 countsByYear W20170088702012 @default.
• W2017008870 countsByYear W20170088702014 @default.
• W2017008870 countsByYear W20170088702015 @default.
• W2017008870 countsByYear W20170088702016 @default.
• W2017008870 countsByYear W20170088702017 @default.
• W2017008870 countsByYear W20170088702018 @default.
• W2017008870 countsByYear W20170088702019 @default.
• W2017008870 countsByYear W20170088702020 @default.
• W2017008870 countsByYear W20170088702021 @default.
• W2017008870 countsByYear W20170088702022 @default.
• W2017008870 countsByYear W20170088702023 @default.
• W2017008870 crossrefType "journal-article" @default.
• W2017008870 hasAuthorship W2017008870A5020166018 @default.
• W2017008870 hasAuthorship W2017008870A5053694613 @default.
• W2017008870 hasConcept C126322002 @default.
• W2017008870 hasConcept C126894567 @default.
• W2017008870 hasConcept C141071460 @default.
• W2017008870 hasConcept C175768497 @default.
• W2017008870 hasConcept C2777085111 @default.
• W2017008870 hasConcept C2777478456 @default.
• W2017008870 hasConcept C2779091618 @default.
• W2017008870 hasConcept C42219234 @default.
• W2017008870 hasConcept C71924100 @default.
• W2017008870 hasConcept C77411442 @default.
• W2017008870 hasConcept C88537330 @default.
• W2017008870 hasConceptScore W2017008870C126322002 @default.
• W2017008870 hasConceptScore W2017008870C126894567 @default.
• W2017008870 hasConceptScore W2017008870C141071460 @default.
• W2017008870 hasConceptScore W2017008870C175768497 @default.
• W2017008870 hasConceptScore W2017008870C2777085111 @default.
• W2017008870 hasConceptScore W2017008870C2777478456 @default.
• W2017008870 hasConceptScore W2017008870C2779091618 @default.
• W2017008870 hasConceptScore W2017008870C42219234 @default.
• W2017008870 hasConceptScore W2017008870C71924100 @default.
• W2017008870 hasConceptScore W2017008870C77411442 @default.
• W2017008870 hasConceptScore W2017008870C88537330 @default.
• W2017008870 hasIssue "2" @default.
• W2017008870 hasLocation W20170088701 @default.
• W2017008870 hasLocation W20170088702 @default.
• W2017008870 hasOpenAccess W2017008870 @default.
• W2017008870 hasPrimaryLocation W20170088701 @default.
• W2017008870 hasRelatedWork W1498784877 @default.
• W2017008870 hasRelatedWork W2017008870 @default.
• W2017008870 hasRelatedWork W2021237894 @default.
• W2017008870 hasRelatedWork W2081468387 @default.
• W2017008870 hasRelatedWork W2099874874 @default.
• W2017008870 hasRelatedWork W2133124362 @default.
• W2017008870 hasRelatedWork W2389225341 @default.
• W2017008870 hasRelatedWork W2413486660 @default.
• W2017008870 hasRelatedWork W2442980851 @default.
• W2017008870 hasRelatedWork W941733843 @default.
• W2017008870 hasVolume "73" @default.
• W2017008870 isParatext "false" @default.
• W2017008870 isRetracted "false" @default.
• W2017008870 magId "2017008870" @default.
• W2017008870 workType "article" @default.